Barrett is a Senior Director of Cell Process Development and CMC Portfolio Management at Prime Medicine, where he is responsible for the process development and manufacturing sciences activities supporting Prime Edited cell therapy products. Prior to Prime, Barrett headed Analytical Development/Quality Control at Repertoire Immune Medicines supporting both cell therapy and biologics programs. He has also worked on other complex advanced therapies, including ADCs and other conjugated biomolecules, in the biotech industry.